TABLE 3.
WHO outcomes of clinical pharmacy services for TB care management.
| Outcome | Tang et al. (2018) | Tanvejsilp et al. (2018) | |||||
|---|---|---|---|---|---|---|---|
| Pharmaceutical care | Usual care | p-value | Pharmaceutical care | Home visit | SAT | p-value | |
| Treatment success | 72% | 54% | 0.137 | 93.1%* | 97.3%* | 83.7%* | - |
| Treatment completion | 19% | 14% | 0.762 | 6.9% | 36.8% | 40.5% | 0.001 |
| Cure | 53% | 40% | 0.373 | 86.2% | 60.5% | 43.2% | |
| Default | 5% | 19% | 0.052 | 0% | 0% | 10.8% | |
| Death | 3% | 3% | 0.979 | 0% | 2.6% | 5.4% | |
| Not completed | - | - | - | 6.9% | 0% | 0% | |
| Failure | 10% | 6% | 0.611 | - | - | - | - |
| Transfer out | 10% | 18% | 0.443 | - | - | - | - |
a
Sum of treatment completion and cure outcomes
SAT, self-administered therapy